Aradigm
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Aradigm and buy or sell other stocks, ETFs, and their options commission-free!About ARDMQ
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.
CEOJohn M. Siebert, PhD
CEOJohn M. Siebert, PhD
Employees—
Employees—
HeadquartersHayward, California
HeadquartersHayward, California
Founded1991
Founded1991
Employees—
Employees—
ARDMQ Key Statistics
Market cap702.90K
Market cap702.90K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume19.67K
Average volume19.67K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.20
52 Week high$0.20
52 Week low$0.016
52 Week low$0.016
Stock Snapshot
With a market cap of 702.9K, Aradigm(ARDMQ) trades at $0.05.
During the trading day, Aradigm(ARDMQ) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 19.67K.
The stock's 52-week range extends from a low of $0.02 to a high of $0.20.
The stock's 52-week range extends from a low of $0.02 to a high of $0.20.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.